BIOREGENX, INC. Proceeds from Notes Payable
BIOREGENX, INC. (BRGX) reported Proceeds from Notes Payable of $5.81 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-05-20
- BIOREGENX, INC. proceeds from notes payable for the quarter ending 2026-03-31 was $5.81K.
- BIOREGENX, INC. proceeds from notes payable for the quarter ending 2025-12-31 was -$1.00.
- BIOREGENX, INC. proceeds from notes payable for the quarter ending 2025-09-30 was $117.51K, a 107.05% increase year-over-year.
- BIOREGENX, INC. proceeds from notes payable for the quarter ending 2025-06-30 was $30.00K, a 70.00% decline year-over-year.
- BIOREGENX, INC. proceeds from notes payable for fiscal 2025 was $147.51K, a 65.47% decline from fiscal 2024.
- BIOREGENX, INC. proceeds from notes payable for fiscal 2024 was $427.19K, a 478.43% increase from fiscal 2023.
- BIOREGENX, INC. proceeds from notes payable for fiscal 2023 was $73.85K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 3 month as first filed | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $5.81K 10-Q · filed 2026-05-20 | $5.81K derived: sum of 2 quarters · filed 2026-05-20 | $123.32K derived: sum of 3 quarters · filed 2026-05-20 | $153.32K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $117.51K derived: sum of 2 quarters · filed 2026-04-15 | $147.51K derived: sum of 3 quarters · filed 2026-04-15 | $147.51K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $117.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $147.51K derived: sum of 2 quarters · filed 2025-11-14 | $147.51K 10-Q · filed 2025-11-14 | $117.94K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $30.00K 10-Q · filed 2025-08-14 | $433.00 derived: sum of 3 quarters · filed 2026-05-20 | $57.19K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-20 | -$29.57K derived: sum of 2 quarters · filed 2026-05-20 | $27.19K derived: sum of 3 quarters · filed 2026-05-20 | $127.19K derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | -$29.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $27.19K derived: sum of 2 quarters · filed 2026-04-15 | $127.19K derived: sum of 3 quarters · filed 2026-04-15 | $427.19K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $56.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $156.75K derived: sum of 2 quarters · filed 2025-11-14 | $456.75K 10-Q · filed 2025-11-14 | $459.40K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $400.00K 10-Q · filed 2025-08-14 | $402.64K derived: sum of 3 quarters · filed 2025-08-14 | $473.85K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-15 | $306.82K 10-Q/A · filed 2024-05-29 | $302.64K derived: sum of 2 quarters · filed 2025-05-15 | $373.85K derived: sum of 3 quarters · filed 2025-05-15 | $373.85K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $73.85K derived: sum of 2 quarters · filed 2025-04-16 | $73.85K derived: sum of 3 quarters · filed 2025-04-16 | $73.85K 10-K/A · filed 2025-04-16 | |
| 2023-09-30 | $71.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $71.21K derived: sum of 2 quarters · filed 2024-11-14 | $71.21K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-10-09 | $0.00 10-Q · filed 2024-10-09 | |||
| 2023-03-31 | $0.00 10-Q/A · filed 2024-10-09 | $831.00 10-Q/A · filed 2024-05-29 |